JACC. Heart failure, 2213-1779
Journal
1 - 45 out of 45Page size: 50
- 2020
- Ezekowitz, J. A., O'Connor, C. M., Troughton, R. W., Alemayehu, W. G., Westerhout, C. M., Voors, A. A., Butler, J., Lam, C. S. P., Ponikowski, P., Emdin, M., Patel, M. J., Pieske, B., Roessig, L., Hernandez, A. F., & Armstrong, P. W. (2020). N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes. JACC. Heart failure, 8(11), 931-939. https://doi.org/10.1016/j.jchf.2020.08.008
- Gorter, T. M., van Woerden, G., Rienstra, M., Dickinson, M. G., Hummel, Y. M., Voors, A. A., Hoendermis, E. S., & van Veldhuisen, D. J. (2020). Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction. JACC. Heart failure, 8(8), 667-676. https://doi.org/10.1016/j.jchf.2020.06.003
- Nunez, J., Bayes-Genis, A., Revuelta-Lopez, E., ter Maaten, J. M., Minana, G., Barallat, J., Cserkoova, A., Bodi, V., Fernandez-Cisnal, A., Nunez, E., Sanchis, J., Lang, C., Ng, L. L., Metra, M., & Voors, A. A. (2020). Clinical Role of CA125 in Worsening Heart Failure A BIOSTAT-CHF Study Subanalysis. JACC. Heart failure, 8(5), 386-397. https://doi.org/10.1016/j.jchf.2019.12.005
- Cunningham, J. W., Vaduganathan, M., Claggett, B. L., Zile, M. R., Anand, I. S., Packer, M., Zannad, F., Lam, C. S. P., Janssens, S., Jhund, P. S., Kober, L., Rouleau, J., Shah, S. J., Chopra, V. K., Shi, V. C., Lefkowitz, M. P., Prescott, M. F., Pfeffer, M. A., McMurray, J. J., & Solomon, S. D. (2020). Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Election Fraction. JACC. Heart failure, 8(5), 372-381. https://doi.org/10.1016/j.jchf.2020.03.002
- Cunningham, J. W., Ferreira, J. P., Deng, H., Anker, S. D., Byra, W. M., Cleland, J. G. F., Gheorghiade, M., Lam, C. S. P., La Police, D., Mehra, M. R., Neaton, J. D., Spiro, T. E., van Veldhuisen, D. J., Greenberg, B., & Zannad, F. (2020). Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial Insights From COMMANDER HF. JACC. Heart failure, 8(5), 359-368. https://doi.org/10.1016/j.jchf.2019.12.009
- Tromp, J., Voors, A. A., Sharma, A., Ferreira, J. P., Ouwerkerk, W., Hillege, H. L., Gomez, K. A., Dickstein, K., Anker, S. D., Metra, M., Lang, C. C., Ng, L. L., van der Harst, P., van Veldhuisen, D. J., van Der Meer, P., Lam, C. S. P., Zannad, F., & Sama, I. E. (2020). Distinct Pathological Pathways in Patients With Heart Failure and Diabetes. JACC. Heart failure, 8(3), 234-242. https://doi.org/10.1016/j.jchf.2019.11.005
- Li, J., Woodward, M., Perkovic, V., Figtree, G. A., Heerspink, H. J. L., Mahaffey, K. W., de Zeeuw, D., Vercruysse, F., Shaw, W., Matthews, D. R., & Neal, B. (2020). Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes. JACC. Heart failure, 8(1), 57-66. https://doi.org/10.1016/j.jchf.2019.08.004
- 2019
- Beusekamp, J. C., Tromp, J., Cleland, J. G. F., Givertz, M. M., Metra, M., O'Connor, C. M., Teerlink, J. R., Ponikowski, P., Ouwerkerk, W., van Veldhuisen, D. J., Voors, A. A., & van der Meer, P. (2019). Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. JACC. Heart failure, 7(11), 970-979. https://doi.org/10.1016/j.jchf.2019.07.010
- PARAGON-HF Investigators, Chandra, A., Vaduganathan, M., Lewis, E. F., Claggett, B. L., Rizkala, A. R., Wang, W., Lefkowitz, M. P., Shi, V. C., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., Redfield, M. M., Rouleau, J. L., ... Solomon, S. D. (2019). Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial. JACC. Heart failure, 7(10), 862-874. https://doi.org/10.1016/j.jchf.2019.05.015
- GENETIC-AF Trial Investigators, Piccini, J. P., Abraham, W. T., Dufton, C., Carroll, I. A., Healey, J. S., van Veldhuisen, D. J., Sauer, W. H., Anand, I. S., White, M., Wilton, S. B., Aleong, R., Rienstra, M., Krueger, S. K., Ayala-Paredes, F., Khaykin, Y., Merkely, B., Miloradovic, V., Wranicz, J. K., ... Connolly, S. J. (2019). Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial. JACC. Heart failure, 7(7), 586-598. https://doi.org/10.1016/j.jchf.2019.04.004
- ter Maaten, J. M., & Voors, A. A. (2019). Time to Revisit the Value of Urine Collections in Heart Failure. JACC. Heart failure, 7(5), 392-393. https://doi.org/10.1016/j.jchf.2019.01.015
- Martens, P., Dupont, M., Verbrugge, F. H., Damman, K., Degryse, N., Nijst, P., Reynders, C., Penders, J., Tang, W. H. W., Testani, J., & Mullens, W. (2019). Urinary Sodium Profiling in Chronic Heart Failure to Detect Development of Acute Decompensated Heart Failure. JACC. Heart failure, 7(5), 404-414. https://doi.org/10.1016/j.jchf.2019.02.011
- Wolsk, E., Kaye, D., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Lam, C. S. P., van Veldhuisen, D. J., Ponikowski, P., Petrie, M. C., Hassager, C., Moller, J. E., & Gustafsson, F. (2019). Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction. JACC. Heart failure, 7(4), 321-332. https://doi.org/10.1016/j.jchf.2019.01.006
- Savarese, G., Vedin, O., D'Amario, D., Uijl, A., Dahlstrom, U., Rosano, G., Lam, C. S. P., & Lund, L. H. (2019). Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure. JACC. Heart failure, 7(4), 306-317. https://doi.org/10.1016/j.jchf.2018.11.019
- Beldhuis, I. E., Myhre, P. L., Claggett, B., Damman, K., Fang, J. C., Lewis, E. F., O'Meara, E., Pitt, B., Shah, S. J., Voors, A. A., Pfeffer, M. A., Solomon, S. D., & Desai, A. S. (2019). Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease. JACC. Heart failure, 7(1), 25-32. https://doi.org/10.1016/j.jchf.2018.10.017
- 2018
- Lam, C. S. P., & Chandramouli, C. (2018). Fat, Female, Fatigued Features of the Obese HFpEF Phenotype. JACC. Heart failure, 6(8), 710-713. https://doi.org/10.1016/j.jchf.2018.06.006
- Savji, N., Meijers, W. C., Bartz, T. M., Bhambhani, V., Cushman, M., Nayor, M., Kizer, J. R., Sarma, A., Blaha, M. J., Gansevoort, R. T., Gardin, J. M., Hillege, H. L., Ji, F., Kop, W. J., Lau, E. S., Lee, D. S., Sadreyev, R., van Gilst, W. H., Wang, T. J., ... Ho, J. E. (2018). The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF. JACC. Heart failure, 6(8), 701-709. https://doi.org/10.1016/j.jchf.2018.05.018
- Damman, K., Gori, M., Claggett, B., Jhund, P. S., Senni, M., Lefkowitz, M. P., Prescott, M. F., Shi, V. C., Rouleau, J. L., Swedberg, K., Zile, M. R., Packer, M., Desai, A. S., Solomon, S. D., & McMurray, J. J. V. (2018). Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC. Heart failure, 6(6), 489-498. https://doi.org/10.1016/j.jchf.2018.02.004
- Cerbin, L. P., Ambrosy, A. P., Greene, S. J., Armstrong, P. W., Butler, J., Coles, A., DeVore, A. D., Ezekowitz, J. A., Hernandez, A. F., Metra, M., Starling, R. C., Tang, W., Teerlink, J. R., Voors, A. A., Wu, A., O'Connor, C. M., & Mentz, R. J. (2018). Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. JACC. Heart failure, 6(4), 298-307. https://doi.org/10.1016/j.jchf.2018.01.018
- Armstrong, P. W., Roessig, L., Patel, M. J., Anstrom, K. J., Butler, J., Voors, A. A., Lam, C. S. P., Ponikowski, P., Temple, T., Pieske, B., Ezekowitz, J., Hernandez, A. F., Koglin, J., & O'Connor, C. M. (2018). A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator The VICTORIA Trial. JACC. Heart failure, 6(2), 96-104. https://doi.org/10.1016/j.jchf.2017.08.013
- 2017
- Solomon, S. D., Rizkala, A. R., Gong, J., Wang, W., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., Redfield, M. M., Rouleau, J. L., Van Veldhuisen, D. J., Zannad, F., Zile, M. R., Desai, A. S., Shi, V. C., ... McMurray, J. J. V. (2017). Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction Rationale and Design of the PARAGON-HF Trial. JACC. Heart failure, 5(7), 471-482. https://doi.org/10.1016/j.jchf.2017.04.013
- Tromp, J., Khan, M. A. F., Mentz, R. J., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G. F., Givertz, M. M., Bloomfield, D. M., Van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., & van der Meer, P. (2017). Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction. JACC. Heart failure, 5(7), 507-517. https://doi.org/10.1016/j.jchf.2017.04.007
- O'Connor, C. M., & van Veldhuisen, D. J. (2017). Data Sharing From the Editors' Perspective Our Hope With Limitations. JACC. Heart failure, 5(4), 314-315. https://doi.org/10.1016/j.jchf.2017.02.007
- Aimo, A., Vergaro, G., Ripoli, A., Bayes-Genis, A., Pascual Figal, D. A., de Boer, R. A., Lassus, J., Mebazaa, A., Gayat, E., Breidthardt, T., Sabti, Z., Mueller, C., Brunner-La Rocca, H-P., Tang, W. H. W., Grodin, J. L., Zhang, Y., Bettencourt, P., Maisel, A. S., Passino, C., ... Emdin, M. (2017). Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure. JACC. Heart failure, 5(4), 287-296. https://doi.org/10.1016/j.jchf.2016.12.016
- Lam, C. S. P., Rienstra, M., Tay, W-T., Liu, L. C. Y., Hummel, Y. M., van der Meer, P., de Boer, R. A., Van Gelder, I. C., van Veldhuisen, D. J., Voors, A. A., & Hoendermis, E. S. (2017). Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. JACC. Heart failure, 5(2), 92-98. https://doi.org/10.1016/j.jchf.2016.10.005
- Ambrosy, A. P., Cerbin, L. P., Armstrong, P. W., Butler, J., Coles, A., DeVore, A. D., Dunlap, M. E., Ezekowitz, J. A., Felker, G. M., Fudim, M., Greene, S. J., Hernandez, A. F., O'Connor, C. M., Schulte, P., Starling, R. C., Teerlink, J. R., Voors, A. A., & Mentz, R. J. (2017). Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial. JACC. Heart failure, 5(1), 1-13. https://doi.org/10.1016/j.jchf.2016.09.012
- 2016
- Meems, L. M. G., Brouwers, F. P., Joosten, M. M., Lambers Heerspink, H. J., de Zeeuw, D., Bakker, S. J. L., Gansevoort, R. T., van Gilst, W. H., van der Harst, P., & de Boer, R. A. (2016). Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort study. JACC. Heart failure, 3(3), 189-197. https://doi.org/10.1002/ehf2.12089
- Testani, J. M., & ter Maaten, J. M. (2016). Decongestion in Acute Heart Failure Does the End Justify the Means? JACC. Heart failure, 4(7), 589-590. https://doi.org/10.1016/j.jchf.2016.03.024
- Pang, P. S., Teerlink, J. R., Voors, A. A., Ponikowski, P., Greenberg, B. H., Filippatos, G., Felker, G. M., Davison, B. A., Cotter, G., Kriger, J., Prescott, M. F., Hua, T. A., Severin, T., & Metra, M. (2016). Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes An Exploratory Analysis From the RELAX-AHF Trial. JACC. Heart failure, 4(7), 591-599. https://doi.org/10.1016/j.jchf.2016.02.009
- Zipes, D. P., Neuzil, P., Theres, H., Caraway, D., Mann, D. L., Mannheimer, C., Van Buren, P., Linde, C., Linderoth, B., Kueffer, F., Sarazin, S. A., DeJongste, M. J. L., & DEFEAT-HF Trial Investigators (2016). Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure The DEFEAT-HF Study. JACC. Heart failure, 4(2), 129-136. https://doi.org/10.1016/j.jchf.2015.10.006
- Tang, W. H. W., Wu, Y., Grodin, J. L., Hsu, A. P., Hernandez, A. F., Butler, J., Metra, M., Voors, A. A., Felker, G. M., Troughton, R. W., Mills, R. M., McMurray, J. J., Armstrong, P. W., O'Connor, C. M., & Starling, R. C. (2016). Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. JACC. Heart failure, 4(1), 68-77. https://doi.org/10.1016/j.jchf.2015.07.015
- 2015
- Voors, A. A., & ter Maaten, J. M. (2015). Tackling Early Heart Failure Deaths and Readmissions by Estimating Congestion. JACC. Heart failure, 3(11), 894-895. https://doi.org/10.1016/j.jchf.2015.06.013
- Grodin, J. L., Perez, A. L., Wu, Y., Hernandez, A. F., Butler, J., Metra, M., Felker, G. M., Voors, A. A., McMurray, J. J., Armstrong, P. W., Califf, R. M., Starling, R. C., O'Connor, C. M., & Tang, W. H. W. (2015). Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). JACC. Heart failure, 3(10), 777-785. https://doi.org/10.1016/j.jchf.2015.06.006
- Davison, B. A., Metra, M., Cotter, G., Massie, B. M., Cleland, J. G. F., Dittrich, H. C., Edwards, C., Filippatos, G., Givertz, M. M., Greenberg, B., Ponikowski, P., Voors, A. A., O'Connor, C. M., Teerlink, J. R., & PROTECT & RELAX-AHF Executive Comm (2015). Worsening Heart Failure Following Admission for Acute Heart Failure A Pooled Analysis of the PROTECT and RELAX-AHF Studies. JACC. Heart failure, 3(5), 395-403. https://doi.org/10.1016/j.jchf.2015.01.007
- Felker, G. M., Butler, J., Collins, S. P., Cotter, G., Davison, B. A., Ezekowitz, J. A., Filippatos, G., Levy, P. D., Metra, M., Ponikowski, P., Soergel, D. G., Teerlink, J. R., Violin, J. D., Voors, A. A., & Pang, P. S. (2015). Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor Rationale and Design of the BLAST-AHF Study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure). JACC. Heart failure, 3(3), 193-201. https://doi.org/10.1016/j.jchf.2014.09.008
- Tang, W. H. W., Dupont, M., Hernandez, A. F., Voors, A. A., Hsu, A. P., Felker, G. M., Butler, J., Metra, M., Anker, S. D., Troughton, R. W., Gottlieb, S. S., McMurray, J. J., Armstrong, P. W., Massie, B. M., Califf, R. M., O'Connor, C. M., & Starling, R. C. (2015). Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial. JACC. Heart failure, 3(1), 40-49. https://doi.org/10.1016/j.jchf.2014.06.014
- 2013
- Damman, K., Masson, S., Hillege, H. L., Voors, A. A., van Veldhuisen, D. J., Rossignol, P., Proietti, G., Barbuzzi, S., Nicolosi, G. L., Tavazzi, L., Maggioni, A. P., & Latini, R. (2013). Tubular Damage and Worsening Renal Function in Chronic Heart Failure. JACC. Heart failure, 1(5), 417-424. https://doi.org/10.1016/j.jchf.2013.05.007
- de Boer, R. A., Cao, Q., Postmus, D., Damman, K., Voors, A. A., Jaarsma, T., van Veldhuisen, D. J., Arnold, W. D., Hillege, H. L., & Sillje, H. H. W. (2013). The WAP Four-Disulfide Core Domain Protein HE4: A Novel Biomarker for Heart Failure. JACC. Heart failure, 1(2), 164-169. https://doi.org/10.1016/j.jchf.2012.11.005
- Sanders-van Wijk, S., van Asselt, A. D. I., Rickli, H., Estlinbaum, W., Erne, P., Rickenbacher, P., Vuillomenet, A., Peter, M., Pfisterer, M. E., Brunner-La Rocca, H-P., & TIME-CHF Investigators (2013). Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure). JACC. Heart failure, 1(1), 64-71. https://doi.org/10.1016/j.jchf.2012.08.002
ID: 14240803